503 related articles for article (PubMed ID: 12060398)
21. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
[TBL] [Abstract][Full Text] [Related]
22. p53 codon 72 polymorphism and HPV status in lung cancer.
Buyru N; Altinisik J; Isin M; Dalay N
Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.
Shamanin V; zur Hausen H; Lavergne D; Proby CM; Leigh IM; Neumann C; Hamm H; Goos M; Haustein UF; Jung EG; Plewig G; Wolff H; de Villiers EM
J Natl Cancer Inst; 1996 Jun; 88(12):802-11. PubMed ID: 8637046
[TBL] [Abstract][Full Text] [Related]
25. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.
Harwood CA; Surentheran T; McGregor JM; Spink PJ; Leigh IM; Breuer J; Proby CM
J Med Virol; 2000 Jul; 61(3):289-97. PubMed ID: 10861635
[TBL] [Abstract][Full Text] [Related]
27. Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion.
Alotaibi L; Provost N; Gagnon S; Franco EL; Coutlée F
J Clin Virol; 2006 Jun; 36(2):133-40. PubMed ID: 16678481
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts.
Biliris KA; Koumantakis E; Dokianakis DN; Sourvinos G; Spandidos DA
Cancer Lett; 2000 Dec; 161(1):83-8. PubMed ID: 11078916
[TBL] [Abstract][Full Text] [Related]
29. TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions.
Humbey O; Aubin F; Cairey-Remonnay S; Riethmuller D; Pretet JL; Fest T; Seilles E; Mougin C
Eur J Obstet Gynecol Reprod Biol; 2002 Jun; 103(1):60-4. PubMed ID: 12039466
[TBL] [Abstract][Full Text] [Related]
30. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer.
Summersgill KF; Smith EM; Kirchner HL; Haugen TH; Turek LP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Sep; 90(3):334-9. PubMed ID: 10982955
[TBL] [Abstract][Full Text] [Related]
31. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
[TBL] [Abstract][Full Text] [Related]
32. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?
Bastiaens MT; Struyk L; Tjong-A-Hung SP; Gruis N; ter Huurne J; Westendorp RG; Vermeer BJ; Bavinck JN; ter Schegget J
Mol Carcinog; 2001 Jan; 30(1):56-61. PubMed ID: 11255264
[TBL] [Abstract][Full Text] [Related]
34. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients.
Brown MR; Noffsinger A; First MR; Penn I; Husseinzadeh N
Gynecol Oncol; 2000 Nov; 79(2):220-4. PubMed ID: 11063648
[TBL] [Abstract][Full Text] [Related]
35. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
[TBL] [Abstract][Full Text] [Related]
36. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
37. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation.
Kataoka A; Nishida T; Sugiyama T; Hori K; Honda S; Yakushiji M
Gynecol Oncol; 1997 Apr; 65(1):180-4. PubMed ID: 9103411
[TBL] [Abstract][Full Text] [Related]
38. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
Queille S; Luron L; Spatz A; Avril MF; Ribrag V; Duvillard P; Hiesse C; Sarasin A; Armand JP; Daya-Grosjean L
Carcinogenesis; 2007 Mar; 28(3):724-31. PubMed ID: 17065198
[TBL] [Abstract][Full Text] [Related]
39. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus.
Snijders PJ; Steenbergen RD; Top B; Scott SD; Meijer CJ; Walboomers JM
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2769-75. PubMed ID: 7931165
[TBL] [Abstract][Full Text] [Related]
40. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
